In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Celestica, Inc (NYSE: CLS) closed at $235.34 up 0.71% from its previous closing price of $233.67. In other words, the price has increased by $0.71 from its previous closing price. On the day, 2.69 million shares were traded. CLS stock price reached its highest trading level at $244.58 during the session, while it also had its lowest trading level at $233.87.
Ratios:
For a deeper understanding of Celestica, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 86.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 70.36. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.55.
On July 21, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $172.
On February 21, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $166.JP Morgan initiated its Overweight rating on February 21, 2025, with a $166 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when Wilson Michael Max sold 25,000 shares for $98.73 per share. The transaction valued at 2,468,250 led to the insider holds 1,784 shares of the business.
Agrawal Alok K. bought 3,672 shares of CLS for $438,694 on May 30 ’25. On Mar 31 ’25, another insider, Laurette Koellner, who serves as the Director of the company, bought 100,000 shares for $82.69 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 27071793152 and an Enterprise Value of 27771092992. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 51.12, and their Forward P/E ratio for the next fiscal year is 34.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.56 while its Price-to-Book (P/B) ratio in mrq is 15.40. Its current Enterprise Value per Revenue stands at 2.623 whereas that against EBITDA is 30.186.
Stock Price History:
The Beta on a monthly basis for CLS is 1.84, which has changed by 3.2243762 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $261.83, while it has fallen to a 52-week low of $52.25. The 50-Day Moving Average of the stock is 7.05%, while the 200-Day Moving Average is calculated to be 69.41%.
Shares Statistics:
For the past three months, CLS has traded an average of 3.39M shares per day and 2595180 over the past ten days. A total of 115.00M shares are outstanding, with a floating share count of 114.44M. Insiders hold about 0.51% of the company’s shares, while institutions hold 74.41% stake in the company. Shares short for CLS as of 1757894400 were 5001788 with a Short Ratio of 1.48, compared to 1755216000 on 5948533. Therefore, it implies a Short% of Shares Outstanding of 5001788 and a Short% of Float of 4.37.
Earnings Estimates
The market rating for Celestica, Inc (CLS) is a result of the insights provided by 13.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $1.5, with high estimates of $1.61 and low estimates of $1.38.
Analysts are recommending an EPS of between $5.89 and $5.45 for the fiscal current year, implying an average EPS of $5.58. EPS for the following year is $6.87, with 15.0 analysts recommending between $8.6 and $6.35.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $3.02B this quarter.It ranges from a high estimate of $3.09B to a low estimate of $2.99B. As of. The current estimate, Celestica, Inc’s year-ago sales were $2.5BFor the next quarter, 12 analysts are estimating revenue of $3.05B. There is a high estimate of $3.15B for the next quarter, whereas the lowest estimate is $2.82B.
A total of 14 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.12B, while the lowest revenue estimate was $11.38B, resulting in an average revenue estimate of $11.66B. In the same quarter a year ago, actual revenue was $9.65BBased on 13 analysts’ estimates, the company’s revenue will be $13.68B in the next fiscal year. The high estimate is $14.32B and the low estimate is $13.3B.